Board-Certified Urologist | Men’s Health & Sexual Medicine Specialist | Clinical Research Leader

Dr. Jed Kaminetsky is a board-certified urologist on the faculty of NYU Grossman School of Medicine, and Fellow of the American College of Surgeons specializing in men’s health, sexual medicine, and minimally invasive urologic therapies. He is a nationally recognized thought leader in the treatment of BPH, erectile dysfunction, hypogonadism, and Peyronie’s disease.

Dr. Kaminetsky graduated from NYU Grossman School of Medicine and completed his urology residency at the same institution, where he has remained on faculty throughout his career. He has built a longstanding reputation as a leader in men’s health and innovative urologic treatments.

He is the founder of Manhattan Medical Research, where he has served as principal investigator in over 100 clinical trials. He is also the Director of Research at Integrated Medical Professionals (IMP). His research contributions include more than 50 peer-reviewed publications and numerous presentations at national and international medical meetings.

Dr. Kaminetsky has also been an early adopter and contributor to the development of several modern urologic therapies, helping advance minimally invasive and office-based treatment options for patients. He has performed over 4000 no scalpel vasectomies in the office.

  • Benign prostatic hyperplasia (BPH)
  • Voiding dysfunction
  • Erectile dysfunction (ED)
  • Hypogonadism (low testosterone)
  • Peyronie’s disease
  • Men’s sexual health and reproductive medicine
  • Office-based minimally invasive urologic procedures
  • No scalpel vasectomy
  • English
  • Italian
  • M.D., NYU Grossman School of Medicine
  • Urology Residency, NYU Grossman School of Medicine
  • American Board of Urology
  • Fellow, American College of Surgeons (FACS)
  • American Urological Association
  • Sexual Medicine Society of North America
  • Clinical research investigator network (men’s health and urologic innovation trials)
  • NYU Langone Health (faculty affiliation)
  • Manhattan outpatient urology and men’s health practices

Dr. Kaminetsky has authored over 50 peer-reviewed publications and has contributed extensively to clinical research in men’s health and sexual medicine. He has served as principal investigator in over 100 clinical trials through Manhattan Medical Research.

His research and presentations focus on:

  • BPH and minimally invasive therapies (Rezum™, UroLift®, GreenLight™)
  • Erectile dysfunction and restorative therapies
  • Hypogonadism and testosterone replacement therapy (e.g., Testopel®)
  • Peyronie’s disease treatment (e.g., Xiaflex®)
  • Shockwave therapy for erectile function
  • Castle Connolly Top Doctors
  • Founder, Manhattan Medical Research
  • Principal Investigator in 100+ clinical trials
  • Recognized leader in development and adoption of minimally invasive men’s health therapies
  • Extensive national and international speaking faculty in urologic innovation